Prognostic value of bronchiectasis in patients with moderate-to-severe chronic obstructive pulmonary disease

American Journal of Respiratory and Critical Care Medicine

Volumn 187, Issue 8, 2013, Pages 823-831

  Martińez García, Miguel Angel ^a,b   Carrillo, David De La Rosa ^c   Soler Catalunã, Juan Jose ^d   Donat Sanz, Yolanda ^d   Serra, Pablo Catalań ^d   Lerma, Marco Agramunt ^d   Ballestiń, Javier ^d   Sańchez, Irene Valero ^a   Ferrer, Maria Jose Selma ^a   Dalfo, Anna Roma ^c   Valdecillos, Montserrat Bertomeu ^c  

^a HOSPITAL UNIVERSITARIO LA FE   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

^c Hospital Platón   (Spain)

^d HOSPITAL GENERAL DE REQUENA   (Spain)

Author keywords

Bronchiectasis; Chronic colonization; Chronic obstructive pulmonary disease; Mortality; Prognostic factor

Indexed keywords

AGED; ARTICLE; BRONCHIECTASIS; CHRONIC OBSTRUCTIVE LUNG DISEASE; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; OBSERVATIONAL STUDY; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY;

AGED; AMBULATORY CARE FACILITIES; BRONCHIECTASIS; COMORBIDITY; DISEASE PROGRESSION; FEMALE; HUMANS; INCIDENCE; KAPLAN-MEIER ESTIMATE; MALE; PREVALENCE; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SEVERITY OF ILLNESS INDEX; SPAIN; SPUTUM; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84876869179     PISSN: 1073449X     EISSN: 15354970     Source Type: Journal    
DOI: 10.1164/rccm.201208-1518OC     Document Type: Article

References (43)

1. Murria CJL, Lopez AD. Mortality by cause for eight regions of the world global burden of disease study. Lancet 1997;349:1269-1276. (Pubitemid 27192468)
2. Anthonisen NR, Wright EC, Hodgkin JE. Prognosis in chronic obstructive pulmonary disease. Am Rev Respir Dis 1986;133:14-20. (Pubitemid 16189089)
3. Celli BR, Cote CG, Marin JM, Casanova C, Montes de Oca M, Mendez RA, Pinto Plata V, Cabral HJ. The body mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. N Engl J Med 2004;350:1005-1012. (Pubitemid 38269277)
4. Oga T, Nishimura K, Tsukino M, Sato S, Hajiro T. Analysis of the factors related to mortality in chronic obstructive pulmonary disease. Role of exercise capacity and health status. Am J Respir Crit Care Med 2003;167:544-549.
5. Vestbo J, Prescott E, Almdal T, Dahl M, Nordestgaard BG, Andersen T, Sorensen TI, Lange P. Body mass, fat-free body mass, and prognosis in patients with chronic obstructive pulmonary disease from a random population sample. Findings from the Copenhagen City Heart Study. Am Respir J Crit Care Med 2006;73:79-83. (Pubitemid 43069791)
6. Domingo-Salvany A, Lamarca R, Ferrer M, Garcia-Aymerich J, Alonso J, Félez M, Khalaf A, Marrades RM, Monsó E, Serra-Battles J, et al. Healthrelated quality of life and mortality in male patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2002;166:680-685. (Pubitemid 34971850)
7. Chatila WM, Thomashow BM, Minai OA, Criner GJ, Make BJ. Comorbidities in chronic obstructive pulmonary disease. Proc Am Thorac Soc 2008;5:549-555. (Pubitemid 351669185)
8. Soler-Cataluña JJ, Martínez-García MA, Román Sánchez P, Salcedo E, Navarro M, Ochando R. Severe acute exacerbations and mortality in patients with obstructive pulmonary disease. Thorax 2005;60: 925-931. (Pubitemid 41598207)
9. Medical Research Council Working Party. Long-term domiciliary oxygen therapy in chronic cor pulmonale complicating chronic bronchitis and emphysema. Lancet 1981;1:681-685.
10. Chailleux E, Laaban JP, Veale D. Prognostic value of nutritional depletion in patients with COPD treated by long-term oxygen therapy: data from the ANTADIR observatory. Chest 2003;123:1460-1466. (Pubitemid 36549763)
11. Casanova C, Cote C, de Torres JP, Aguirre-Jaime A, Marín JM, Pinto- Plata V, Celli BR. Inspiratory-to-total lung capacity ratio predicts mortality in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2005;171:591-597. (Pubitemid 40365414)
12. Cooper GJ, Simmons BE, Castaner A. Elevated pulmonary artery pressure. Chest 1991;99:112-120.
13. Dahl M, Vestbo J, Lange P, Bojesen SE, Tybjaerg-Hansen A, Nordestgaard BG. C-reactive protein as a predictor of prognosis in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2007;175:250-255. (Pubitemid 46203128)
14. Gea J, Barreiro E. Update on the mechanisms of muscle disfunction in COPD. Arch Bronconeumol 2008;44:328-337.
15. O'Donnell AE. Bronchiectasis. Chest 2008;134:815-823.
16. Bilton D. Update on non-cystic fibrosis bronchiectasis. Curr Opin Pulm Med 2008;14:595-599.
17. Patel IS, Vlahos I, Wilkinson TMA, Lloyd-Owen SJ, Donaldson GC, Wilks M, Reznek RH, Wedzicha JA. Bronchiectasis, exacerbations indices, and inflammation in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2004;170:400-407. (Pubitemid 39214614)
18. O'Brien CO, Guest PJ, Hill SL, Stockley RA. Physiological and radiological characterisation of patients diagnosed with chronic obstructive pulmonary disease in primary care. Thorax 2000;55:635-642. (Pubitemid 30468217)
19. Garcia Vidal C, Almagro P, Romani V, Rodriguez-Carballeira M, Cuchi E, Canales L, Blasco D, Heredia JL, Garau J. Pseudomonas aeruginosa in patients hospitalised for COPD exacerbations: a prospective study. Eur Respir J 2009;34:1072-1078.
20. Han MK, Agusti A, Calverley PMA, Celli BR, Criner G, Curtis JL, Fabbri L, Goldin JG, Jones PW, MacNee W, et al. Chronic obstructive pulmonary disease phenotypes. The future of COPD. Am J Respir Crit Care Med 2010;182:598-604.
21. Naidich DP, McCauley DI, Khouri NF, Stitik FP, Siegelman SS. Computed tomography of bronchiectasis. J Comput Assist Tomogr 1982;6:437-444. (Pubitemid 12123025)
22. Vendrell M, De Gracia J, Olveira C, Martínez-García MA, Girón R, Máiz L, Cantón R, Coll R, Escribano A, Solé A. Normativa sobre el diagnóstico y tratamiento de las bronquiectasias. Arch Bronconeumol 2008;44:629-640.
23. Pasteur MC, Bilton D, Hill AT and the British Society Bronchiectasis non-CF Guideline group. British thoracic society guideline for non- CF bronchiectasis. Thorax 2010;65:i1-i58.
24. Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease [updated 2011; accessed 2012 Jun 20. Available from http://www.goldcopd. com/Guidelineitem.asp?l1=2&12=1&intId=2003.
25. Lynch DA, Newell JD, Tschomper BA, Cink TM, Newman LS, Bethel R. Uncomplicated asthma in adults: comparison of CT appearances of the lungs in asthma and healthy subjects. Radiology 1993;188:829-833. (Pubitemid 23254612)
26. Bhalla M, Turcios N, Aponte V, Jenkins M, Leitman BS, McCauley DI, Naidich DP. Cystic fibrosis: scoring systemwith thin-section CT. Radiology 1991;179:783-788.
27. Bestall JC, Paul EA, Garrod R, Garnham R, Jones PW, Wedzicha JA. Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease. Thorax 1999;54:581-586. (Pubitemid 29296676)
28. Charlson ME, Pompei P, Ales KL, MacKencie CRL. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987;40:373-383. (Pubitemid 17055592)
29. Sanchis J, Casan P, Castillo J, González N, Palenciano L, Roca J. Normativas para la práctica de la espirometría forzada. Arch Bronconeumol 1989;25:132-142.
30. Martínez-García MA, Soler-Cataluña JJ, Donat Sanz Y, Catalán Serra P, Agramunt Lerma M, Ballestín Vicente J, Perpiñá-Tordera M. Factors associated with bronchiectasis in chronic obstructive pulmonary disease patients. Chest 2011;140:1130-1137.
31. Murphy TF, Brauer AL, Schiffmacher AT, Sethi S. Persistent colonization by Haemophilus influenzae in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2004;170:266-272. (Pubitemid 38971411)
32. Chin CL, Manzel LJ, Lehman EE, Humlicek AL, Shi L, Starner TD, Denning GM, Murphy TF, Sethi S, Look DC. Haemophilus influenzae from patients with chronic obstructive pulmonary disease exacerbation induce more inflammation than colonizers. Am J Respir Crit Care Med 2005;172:85-91. (Pubitemid 40923318)
33. Sethi S, Evans N, Grant BJ, Murphy TF. New strains of bacteria and exacerbation of chronic obstructive pulmonary disease. N Engl J Med 2002;347:465-471. (Pubitemid 34879333)
34. Cantón R, Cobos N, de Gracia J, Baquero F, Honorato J, Gartner S, Álvarez A, Salcedo A, Oliver A, Garcí a-Quetglas E. Tratamiento antimicrobiano frente a la colonización pulmonar por Pseudomonas aeruginosa en el paciente con fibrosis quística. Arch Bronconeumol 2005;41:1-25.
35. Zalacain R, Sobradillo V, Amilibia J, Barrón J, Achóyegui V, Pijoan JI, Llorente JL. Predisposing factors to bacterial colonization in chronic obstructive pulmonary disease. Eur Respir J 1999;13:343-348. (Pubitemid 29086831)
36. Cole PJ. Inflammation: a two-edged sword-the model of bronchiectasis. Eur J Respir Dis Suppl 1986;147:6-15. (Pubitemid 16017382)
37. Soler-Cataluña JJ, Martínez-Garcí a MA, Sánchez-Sánchez L, Perpiña-Tordera M, Román- Sánchez P. Severe exacerbations and BODE index: two independent risk factors for death in male COPD patients. Respir Med 2009;103:692-699.
38. Sethi S, Jones PW, Theron MS, Miravitlles M, Rubinstein E, Wedzicha JA, Wilson R. Pulsed moxifloxacin for the prevention of exacerbations of chronic obstructive pulmonary disease: a randomized controlled trial. Respir Res 2010;11:10-22.
39. Barker AF, Couch L, Fiel SB, Gotfried MH, Ilowite J, Meyer KC, O'Donnell A, Sahs SA, Smith LJ, Steward JO, et al. Tobramycin solution for inhalation reduces sputum Pseudomonas aeruginosa density in bronchiectasis. Am J Respir Crit Care Med 2000;162:481-485.
40. Drobnic ME, Sune P, Montoro JB, Ferrer A, Orriols R. Inhaled tobramycin in non-cystic fibrosis patients with bronchiectasis and chronic bronchial infection with Pseudomonas aeruginosa. Ann Pharmacother 2005;39:39-44. (Pubitemid 40052376)
41. Orriols R, Roig J, Ferrer J, Sampol G, Rosell A, Ferrer A, Vallano A. Inhaled antibiotic therapy in noncystic fibrosis patients with bronchiectasis and chronic bronchial infection by Pseudomonas aeruginosa. Respir Med 1999;93:476-480. (Pubitemid 29364062)
42. Couch LA. Treatment with tobramycin solution for inhalation in bronchiectasis patients with Pseudomonas aeruginosa. Chest 2001;120:114S-117S. (Pubitemid 32881573)
43. Mair G, Machali J, Miller JJ, McAllister D, Connell M, Murchison JT, MacNee W. Airway dimensions in COPD: relationship with clinical variables. Respir Med 2010;104:1683-1690.